canceldeath

Research feed

Understand the finding first, then explore the evidence. Choose your reading level and sources independently.

Advanced research filters
Clear advanced filters

Dates show original publication, separately from when we added the story. Clinical trials lists registry activity separately. Check collection coverage.

  1. Trial registry · no verified findings· Mayo Clinic

    Fisetin reduced inflammatory markers in elderly women with gait disturbance in a phase 2 RCT

    Published May 11, 2026Added 1moStart a discussionShare on XSenolytics

    AFFIRM was a phase 2 randomized placebo-controlled trial testing fisetin (a senolytic) in older women with gait disturbance. The study aimed to evaluate effects on insulin resistance markers, inflammation, bone resorption, and physical dysfunction. Specific results were not reported in the provided abstract.

    Evidence assessment pending · RCT

    Read the source · Mayo Clinic ↗
  2. Trial registry · no verified findings· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    Dasatinib and Quercetin, a Combination of Senolytics to Treat Fibrotic Non-alcoholic Fatty Liver Disease - the TRUTH Study

    Published Apr 15, 2026Added 1moStart a discussionShare on XSenolytics

    Trial registry update: COMPLETED. No results reported in the supplied registry record.

    Evidence assessment pending · RCT

    Read the source · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) ↗
  3. Trial registry · no verified findings· Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    RCT of immunotherapy plus senolytics versus control before head and neck cancer surgery

    Published Sep 19, 2024Added 1moStart a discussionShare on XSenolytics

    A Phase II randomised controlled trial evaluated tislelizumab (anti-PD-1 antibody) combined with dasatinib and quercetin (senolytics) as neoadjuvant therapy before surgery in patients with head and neck squamous cell carcinoma. The trial assessed efficacy and safety of this combined immunotherapy-senolytic approach.

    Evidence assessment pending · OTHER

    Read the source · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University ↗